Diagnostic value of SpyGlass for pancreatic cystic lesions: comparison of EUS-guided fine-needle aspiration and EUS-guided fine-needle aspiration combined with SpyGlass
- 1 March 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Surgical Endoscopy
- Vol. 36 (2), 904-910
- https://doi.org/10.1007/s00464-021-08347-8
Abstract
Background and aims No study has evaluated the diagnostic value of SpyGlass by comparing SpyGlass results and non-SpyGlass results. In this retrospective study, we aimed to compare the diagnostic value of EUS-guided fine-needle aspiration (EUS-FNA) and EUS-FNA combined with SpyGlass to evaluate whether SpyGlass is valuable for increasing the diagnostic yield of EUS-FNA. Methods From April 2015 to April 2020, 251 patients suspected of having pancreatic cystic lesions (PCLs) by imaging techniques who then underwent EUS-FNA were retrospectively enrolled. Only 98 patients who underwent surgical resection with a pathological diagnosis of pancreatic cystic lesion (PCL) were studied. The diagnostic performance outcomes were compared between the EUS-FNA group (EUS-FNA alone, n = 40) and the SpyGlass group (EUS-FNA combined with SpyGlass, n = 58) to assess the value of SpyGlass in diagnosing PCLs. Results There were 71 females and 27 males with an overall mean age of 47.6 years. The median diameter of the PCLs was 42.2 mm (range, 11.4–100.0 mm). Approximately 37 cysts were localized in the head/neck of the pancreas, while 61 in the body/tail. The sensitivity, specificity, positive predictive value, negative predictive value and diagnostic accuracy of the EUS-FNA group were 96.4% (27/28), 83.3% (10/12), 93.1% (27/29), 90.9% (10/11) and 92.5% (37/40), while those in the SpyGlass group were 100% (54/54), 75% (3/4), 98.2% (54/55), 100% (3/3) and 98.3% (57/58), respectively. The diagnostic accuracy rate in the SpyGlass group was higher than that in the EUS-FNA group; however, no significant difference was found between the two groups (P = 0.368). The diagnostic accuracy of evaluating specific cyst types in the EUS-FNA group was 85% (34/40), similar to that in the SpyGlass group (85.0% vs 84.5%, P = 0.944). Conclusion SpyGlass seems less valuable for the diagnosis of PCLs when EUS and EUS-FNA have been performed by experienced endoscopists.Keywords
Funding Information
- National Key R&D Program of China (2016YFC1303601)
- National Key R&D Program of China (2020YFC2002705)
This publication has 37 references indexed in Scilit:
- Diagnostic and therapeutic utility of single-operator peroral cholangioscopy for indeterminate biliary lesions and bile duct stonesEuropean Journal of Gastroenterology & Hepatology, 2012
- Clinical utility of single-operator cholangiopancreatoscopy using a SpyGlass probe through an endoscopic retrograde cholangiopancreatography catheterJournal of Gastroenterology and Hepatology, 2012
- First assessment of needle-based confocal laser endomicroscopy during EUS-FNA procedures of the pancreas (with videos)Gastrointestinal Endoscopy, 2011
- Single-operator cholangioscopy in patients requiring evaluation of bile duct disease or therapy of biliary stones (with videos)Gastrointestinal Endoscopy, 2011
- SpyGlass pancreatoscopy-guided cannulation and retrieval of a deeply migrated pancreatic duct stentEndoscopy, 2011
- Direct intracystic biopsy and pancreatic cystoscopy through a 19-gauge needle EUS (with videos)Gastrointestinal Endoscopy, 2010
- Endoscopic transpapillary gallbladder drainage with the SpyGlass cholangiopancreatoscopy systemGastrointestinal Endoscopy, 2009
- Taking SpyGlass outside the GI tract lumen in conjunction with EUS to assist in the diagnosis of a pancreatic cystic lesion (with video)Gastrointestinal Endoscopy, 2009
- The Role of Pancreatic Cyst Fluid Molecular Analysis in Predicting Cyst PathologyClinical Gastroenterology and Hepatology, 2005
- Peroral Direct Cholangioscopy (PDCS) Using Routine Straight-view Endoscope: First ReportEndoscopy, 1977